Frontiers in bioengineering and biotechnology: Plant nanoparticles for anti-cancer therapy

19Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Naturally occurring viral nanomaterials have gained popularity owing to their biocompati-ble and biodegradable nature. Plant virus nanoparticles (VNPs) can be used as nanocarriers for a number of biomedical applications. Plant VNPs are inexpensive to produce, safe to administer and efficacious as treatments. The following review describes how plant virus architecture facilitates the use of VNPs for imaging and a variety of therapeutic applications, with particular emphasis on cancer. Examples of plant viruses which have been engineered to carry drugs and diagnostic agents for specific types of cancer are provided. The drug delivery system in response to the internal conditions is known as stimuli response, recently becoming more applicable using plant viruses based VNPs. The review concludes with a perspective of the future of plant VNPs and plant virus-like particles (VLPs) in cancer research and therapy.

Cite

CITATION STYLE

APA

Shoeb, E., Badar, U., Venkataraman, S., & Hefferon, K. (2021, August 1). Frontiers in bioengineering and biotechnology: Plant nanoparticles for anti-cancer therapy. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines9080830

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free